Literature DB >> 10703809

Risk of subsequent invasive breast cancer after breast carcinoma in situ.

F Wärnberg, J Yuen, L Holmberg.   

Abstract

The standardised incidence rates for invasive breast cancer were estimated in a cohort of 3455 women with a primary lobular or ductal carcinoma in situ of the breast.

Entities:  

Mesh：

Year:  2000        PMID： 10703809     DOI： 10.1016/S0140-6736(99)03703-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  21 in total

1.  Postmenopausal hormone therapy and ductal carcinoma in situ: a population-based case-control study.

Authors:  Lisa Calvocoressi; Meredith H Stowe; Darryl Carter; Elizabeth B Claus
Journal:  Cancer Epidemiol       Date:  2012-02-06       Impact factor: 2.984

Review 2.  Suitable trial designs and cohorts for preventive breast cancer agents.

Authors:  Kathrin Strasser-Weippl; Paul E Goss
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

3.  Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ.

Authors:  Vicki Hart McLaughlin; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb; Brian L Sprague
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-08       Impact factor: 4.254

4.  Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Authors:  Matthew W Conklin; Ronald E Gangnon; Brian L Sprague; Lisa Van Gemert; John M Hampton; Kevin W Eliceiri; Jeremy S Bredfeldt; Yuming Liu; Nuntida Surachaicharn; Polly A Newcomb; Andreas Friedl; Patricia J Keely; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

5.  Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Hazel B Nichols; John M Hampton; Polly A Newcomb
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

6.  Structural estimates of treatment effects on outcomes using retrospective data: an application to ductal carcinoma in situ.

Authors:  Heather Taffet Gold; Melony E S Sorbero; Jennifer J Griggs; Huong T Do; Andrew W Dick
Journal:  Med Care Res Rev       Date:  2011-05-19       Impact factor: 3.929

7.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Authors:  Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-06-18       Impact factor: 6.466

8.  Prevalence of breast carcinoma in situ in the United States.

Authors:  Brian L Sprague; Amy Trentham-Dietz
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

9.  Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome.

Authors:  Hind Nassar; Bashar Sharafaldeen; Kala Visvanathan; Daniel Visscher
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

Review 10.  Lobular carcinoma in situ: diagnostic criteria and molecular correlates.

Authors:  Anna Sokolova; Sunil R Lakhani
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.